Cargando…
Leveraging innovative technology to generate drug response phenotypes for the advancement of biomarker‐driven precision dosing
Although traditional approaches to biomarker discovery have elucidated key molecular markers that have improved drug selection (precision medicine), the discovery of biomarkers that inform optimal dose selection (precision dosing) continues to be a challenge in many therapeutic areas. Larger and mor...
Autores principales: | Oni‐Orisan, Akinyemi, Srinivas, Nithya, Mehta, Krina, Das, Jesmin Lohy, Nguyen, Thu T., Tison, Geoffrey H., Bauer, Scott R., Burian, Maria, Funk, Ryan S., Graham, Richard A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212753/ https://www.ncbi.nlm.nih.gov/pubmed/33421282 http://dx.doi.org/10.1111/cts.12973 |
Ejemplares similares
-
Leveraging patient‐centric sampling for clinical drug development and decentralized clinical trials: Promise to reality
por: Maass, Katie F., et al.
Publicado: (2022) -
Novel Coronavirus (COVID-19): Leveraging Telemedicine to Optimize Care While Minimizing Exposures and Viral Transmission
por: Chauhan, Vivek, et al.
Publicado: (2020) -
Advancing precision medicine for acute respiratory distress syndrome
por: Beitler, Jeremy R, et al.
Publicado: (2022) -
Advancing an agile regulatory ecosystem to respond to the rapid development of innovative technologies
por: ElZarrad, M. Khair, et al.
Publicado: (2022) -
Leveraging immune resistance archetypes in solid cancer to inform next-generation anticancer therapies
por: Anderson, Kristin G, et al.
Publicado: (2023)